(Q39116695)

English

Low-molecular contrast agent dynamic contrast-enhanced (DCE)-MRI and diffusion-weighted (DW)-MRI in early assessment of bevacizumab treatment in breast cancer xenografts.

scientific article published on 21 March 2013

Statements

Low-molecular contrast agent dynamic contrast-enhanced (DCE)-MRI and diffusion-weighted (DW)-MRI in early assessment of bevacizumab treatment in breast cancer xenografts. (English)
Siver A Moestue
Else M Huuse
Evita M Lindholm
Anna Bofin
Olav Engebraaten
21 March 2013
1043-1053

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit